default author photo

Gunnstein Bakland

University Hospital of North Norway - Department of Rheumatology

Tromsø

Norway

SCHOLARLY PAPERS

2

DOWNLOADS

146

TOTAL CITATIONS

0

Scholarly Papers (2)

1.

Certolizumab pegol, Abatacept, Tocilizumab or Active Conventional Therapy in Early Rheumatoid Arthritis: 48 Week Patient-Reported Outcomes of the NORD-STAR Trial

Number of pages: 26 Posted: 07 Oct 2025
Karolinska Institutet, University of Helsinki - Helsinki University Hospital, University of Amsterdam - Department of Rheumatology and Clinical Immunology, University of Copenhagen - Department of Clinical Medicine, Diakonhjemmet Hospital, University of Copenhagen, University of Gothenburg - Department of Rheumatology and Inflammation Research, Diakonhjemmet Hospital, University of Amsterdam - Amsterdam Rheumatology and Immunology Centre, Landspitali University Hospital, Karolinska Institutet, University of Southern Denmark, University of Eastern Finland, University of Iceland, University of Copenhagen, Karolinska University Hospital, Sahlgrenska University Hospital, University of Eastern Finland, Lund University, Karolinska Institutet, Diakonhjemmet Hospital, Helsinki University Hospital, Silkeborg Regional Hospital - Diagnostic Centre, Lund University, Uppsala University - Uppsala University Hospital, University of Southern Denmark, University of Amsterdam - Amsterdam Rheumatology and Immunology Centre, Falun Hospital, Ålesund Hospital, University of Bergen - Haukeland University Hospital, Odense University Hospital, Örebro University Hospital, Västmanland´s Hospital, Linkoping University, Karolinska Institutet, Aalborg University, Odense University Hospital, Trondheim University Hospital, Aarhus University, University Hospital of North Norway - Department of Rheumatology, University of Oslo - Department of Research Support for Clinical Trials, Diakonhjemmet Hospital and Diakonhjemmet Hospital
Downloads 95 (730,864)

Abstract:

Loading...

Arthritis, Rheumatoid arthritis, Patient reported outcome, Pain, Fatigue, Biologic drug, TNF, Il-6, Abatacept, Remission

2.

Exploring Drug Cost and Disease Outcome in Rheumatoid Arthritis Patients Treated With Biologic and Targeted Synthetic DMARDs in Norway from 2010 to 2019 – A Country With a National Tender System for Prescription of Costly Drugs

Number of pages: 29 Posted: 18 Aug 2021
Sorlandet Hospital - Research Department, Martina Hansen Hospital - Department of Rheumatology, Diakonhjemmet Hospital - Division of Rheumatology and Research, University of Bergen - Bergen Group of Epidemiology and Biomarkers in Rheumatic Disease, Haugesund Hospital for Rheumatic Diseases, Lillehammer Hospital for Rheumatic Diseases, Betanien Hospital - Department of Rheumatology, Trondheim University Hospital - Department of Rheumatology, University Hospital of North Norway - Department of Rheumatology, District General Hospital of Førde - Section for Rheumatology and Sorlandet Hospital - Research Department
Downloads 51 (1,052,702)

Abstract:

Loading...

Rheumatoid Arthritis, Economics, Biological Therapy, Biosimilar Pharmaceuticals